Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
783,068
-
Share change
-
+376,717
-
Total reported value
-
$5,326,329
-
Price per share
-
$6.92
-
Number of holders
-
28
-
Value change
-
+$2,756,459
-
Number of buys
-
19
-
Number of sells
-
4
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q4 2023
As of 31 Dec 2023,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
783,068 shares.
The largest 10 holders included
VANGUARD GROUP INC, EAM Investors, LLC, Private Advisor Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Imprint Wealth LLC, RENAISSANCE TECHNOLOGIES LLC, COMMONWEALTH EQUITY SERVICES, LLC, NORTHERN TRUST CORP, and TOCQUEVILLE ASSET MANAGEMENT L.P..
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.